T1	AdverseReaction 1264 1276	cardiac risk
T2	Factor 1250 1259	potential
T3	AdverseReaction 2637 2682	transient decreases in sitting blood pressure
T4	AdverseReaction 3960 3978	Prolonged erection
T5	AdverseReaction 4004 4012	priapism
T6	AdverseReaction 4014 4031	painful erections
T7	DrugClass 4096 4111	PDE5 inhibitors
T8	AdverseReaction 4854 4902	non-arteritic anterior ischemic optic neuropathy
T9	AdverseReaction 4904 4909	NAION
T10	AdverseReaction 4944 4960	decreased vision
T11	AdverseReaction 4971 4995	permanent loss of vision
T12	DrugClass 5084 5099	PDE5 inhibitors
T13	AdverseReaction 5411 5416	NAION
T15	DrugClass 5440 5454	PDE5 inhibitor
T16	AdverseReaction 6391 6406	loss of hearing
T17	AdverseReaction 6372 6387;6396 6406	sudden decrease of hearing
T18	DrugClass 6331 6346	PDE5 inhibitors
T19	AdverseReaction 6436 6444	tinnitus
T20	AdverseReaction 6448 6457	dizziness
T22	AdverseReaction 7464 7487	symptomatic hypotension
T23	Factor 7414 7417	can
T24	AdverseReaction 7495 7504	dizziness
T25	AdverseReaction 7506 7521	lightheadedness
T26	AdverseReaction 7523 7531	fainting
T27	AdverseReaction 7802 7825	symptomatic hypotension
T29	DrugClass 7850 7865	PDE5 inhibitors
T36	AdverseReaction 9587 9650	potentiates the anti-aggregatory effect of sodium nitroprusside
T37	Factor 9526 9543	In vitro  studies
T38	Severity 2708 2748	8.0 mmHg systolic and 3.3 mmHg diastolic
T39	AdverseReaction 543 554	hypotension
T40	Severity 3992 3999	4 hours
T41	Severity 4045 4052	6 hours
T42	AdverseReaction 5338 5343	NAION
T43	DrugClass 5274 5289	PDE5 inhibitors
E1	AdverseReaction:T1 Hypothetical:E2
E2	Factor:T2
E3	AdverseReaction:T3 Effect:E38
E4	AdverseReaction:T4 Hypothetical:E7 Effect:E40
E5	AdverseReaction:T5 Hypothetical:E7
E6	AdverseReaction:T6 Hypothetical:E7 Effect:E41
E7	DrugClass:T7
E8	AdverseReaction:T8 Hypothetical:E12
E9	AdverseReaction:T9 Hypothetical:E12
E10	AdverseReaction:T10 Hypothetical:E12
E11	AdverseReaction:T11 Hypothetical:E12
E12	DrugClass:T12
E13	AdverseReaction:T13 Hypothetical2:E15
E15	DrugClass:T15
E16	AdverseReaction:T16 Hypothetical:E18
E17	AdverseReaction:T17 Hypothetical:E18
E18	DrugClass:T18
E19	AdverseReaction:T19 Hypothetical2:E18
E20	AdverseReaction:T20 Hypothetical2:E18
E22	AdverseReaction:T22 Hypothetical:E23
E23	Factor:T23
E24	AdverseReaction:T24 Hypothetical:E23
E25	AdverseReaction:T25 Hypothetical:E23
E26	AdverseReaction:T26 Hypothetical:E23
E27	AdverseReaction:T27 Hypothetical2:E29
E29	DrugClass:T29
E36	AdverseReaction:T36 Hypothetical:E37
E37	Factor:T37
E38	Severity:T38
E39	AdverseReaction:T39
E40	Severity:T40
E41	Severity:T41
E42	AdverseReaction:T42 Hypothetical:E43
E43	DrugClass:T43
A1	CUI E1 C2024776
A2	UMLS-Preferred-Name E1 cardiac risk factors
A3	MEDDRA-PT E1 Cardiac disorder
A4	MEDDRA-PT-ID E1 10061024
A5	CUI E3 C0858766
A6	UMLS-Preferred-Name E3 Blood pressure dropped transient
A7	MEDDRA-PT E3 Blood pressure decreased
A8	MEDDRA-PT-ID E3 10005734
A9	LLT E3 Blood pressure dropped transient
A10	LLT-ID E3 10005745
A11	CUI E4 C2242621
A12	UMLS-Preferred-Name E4 Erection prolonged
A13	MEDDRA-PT E4 Erection increased
A14	MEDDRA-PT-ID E4 10015120
A15	LLT E4 Erection prolonged
A16	LLT-ID E4 10068039
A17	CUI E5 C0033117
A18	UMLS-Preferred-Name E5 Priapism
A19	MEDDRA-PT E5 Priapism
A20	MEDDRA-PT-ID E5 10036661
A21	CUI E6 C0233973
A22	UMLS-Preferred-Name E6 Painful penile erection
A23	MEDDRA-PT E6 Painful erection
A24	MEDDRA-PT-ID E6 10056303
A25	CUI E8 C1852242
A26	UMLS-Preferred-Name E8 Nonarteritic anterior ischemic optic neuropathy (NAION)
A27	MEDDRA-PT E8 Optic ischaemic neuropathy
A28	MEDDRA-PT-ID E8 10030924
A29	LLT E8 Nonarteritic anterior ischaemic optic neuropathy
A30	LLT-ID E8 10068242
A31	CUI E9 C1852242
A32	UMLS-Preferred-Name E9 Nonarteritic anterior ischemic optic neuropathy (NAION)
A33	MEDDRA-PT E9 Optic ischaemic neuropathy
A34	MEDDRA-PT-ID E9 10030924
A35	LLT E9 NAION
A36	LLT-ID E9 10068245
A37	CUI E10 C0558171
A38	UMLS-Preferred-Name E10 Deteriorating vision
A39	MEDDRA-PT E10 Visual acuity reduced
A40	MEDDRA-PT-ID E10 10047531
A41	LLT E10 Vision decreased
A42	LLT-ID E10 10047516
A43	CUI E11 C4012505
A44	UMLS-Preferred-Name E11 Permanent loss of sight
A45	MEDDRA-PT E11 Blindness
A46	MEDDRA-PT-ID E11 10005169
A47	LLT E11 Loss of vision
A48	LLT-ID E11 10024881
A49	CUI E13 C1852242
A50	UMLS-Preferred-Name E13 Nonarteritic anterior ischemic optic neuropathy (NAION)
A51	MEDDRA-PT E13 Optic ischaemic neuropathy
A52	MEDDRA-PT-ID E13 10030924
A53	LLT E13 NAION
A54	LLT-ID E13 10068245
A55	CUI E16 C3887873
A56	UMLS-Preferred-Name E16 Hearing Loss
A57	MEDDRA-PT E16 Deafness
A58	MEDDRA-PT-ID E16 10011878
A59	LLT E16 Hearing loss
A60	LLT-ID E16 10019246
A61	CUI E17 C0011057
A62	UMLS-Preferred-Name E17 Hearing Loss, Sudden
A63	MEDDRA-PT E17 Sudden hearing loss
A64	MEDDRA-PT-ID E17 10061373
A65	CUI E19 C0040264
A66	UMLS-Preferred-Name E19 Tinnitus
A67	MEDDRA-PT E19 Tinnitus
A68	MEDDRA-PT-ID E19 10043882
A69	CUI E20 C0012833
A70	UMLS-Preferred-Name E20 Dizziness
A71	MEDDRA-PT E20 Dizziness
A72	MEDDRA-PT-ID E20 10013573
A73	CUI E22 C0863113
A74	UMLS-Preferred-Name E22 Hypotension symptomatic
A75	MEDDRA-PT E22 Hypotension
A76	MEDDRA-PT-ID E22 10021097
A77	LLT E22 Hypotension symptomatic
A78	LLT-ID E22 10021105
A79	CUI E24 C0012833
A80	UMLS-Preferred-Name E24 Dizziness
A81	MEDDRA-PT E24 Dizziness
A82	MEDDRA-PT-ID E24 10013573
A83	CUI E25 C0220870
A84	UMLS-Preferred-Name E25 Lightheadedness
A85	MEDDRA-PT E25 Dizziness
A86	MEDDRA-PT-ID E25 10013573
A87	LLT E25 Lightheadedness
A88	LLT-ID E25 10024492
A89	CUI E26 C0039070
A90	UMLS-Preferred-Name E26 Syncope
A91	MEDDRA-PT E26 Syncope
A92	MEDDRA-PT-ID E26 10042772
A93	LLT E26 Fainting
A94	LLT-ID E26 10016169
A95	CUI E27 C0863113
A96	UMLS-Preferred-Name E27 Hypotension symptomatic
A97	MEDDRA-PT E27 Hypotension
A98	MEDDRA-PT-ID E27 10021097
A99	LLT E27 Hypotension symptomatic
A100	LLT-ID E27 10021105
A101	flag E36 duplicate
A102	CUI E36 C0919737
A103	UMLS-Preferred-Name E36 Platelet aggregation inhibition
A104	MEDDRA-PT E36 Platelet aggregation inhibition
A105	MEDDRA-PT-ID E36 10050661
A106	CUI E39 C0020649
A107	UMLS-Preferred-Name E39 Hypotension
A108	MEDDRA-PT E39 Hypotension
A109	MEDDRA-PT-ID E39 10021097
A110	CUI E42 C1852242
A111	UMLS-Preferred-Name E42 Nonarteritic anterior ischemic optic neuropathy (NAION)
A112	MEDDRA-PT E42 Optic ischaemic neuropathy
A113	MEDDRA-PT-ID E42 10030924
A114	LLT E42 NAION
A115	LLT-ID E42 10068245
